UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016206
Receipt number R000018796
Scientific Title A phase I/II clinical trial of radical radiotherapy using proton for early breast cancer
Date of disclosure of the study information 2015/01/13
Last modified on 2023/07/21 13:30:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A phase I/II clinical trial of radical radiotherapy using proton for early breast cancer

Acronym

A phase I/II clinical trial of radical radiotherapy using proton for early breast cancer

Scientific Title

A phase I/II clinical trial of radical radiotherapy using proton for early breast cancer

Scientific Title:Acronym

A phase I/II clinical trial of radical radiotherapy using proton for early breast cancer

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Breast surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate safety and effectiveness of proton therapy for low risk stage I breast cancer,and to find optimal treatment dose.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase I,II


Assessment

Primary outcomes

1.Acute toxicities of normal tissue
2.Local control

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Proton therapy 60 to 72GyE/10Fr/12days

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1.Pathologically proven invasive ductal carcinoma(normal type).
2.Tumor size is 2cm or less on MRI.UICC clinical stageI(T1N0M0)
3. No Lymphovascular space invasion(LVSI), No extensive intraductal component(EIC),Estrogen receptor positive.
4.Performance status 0 to 2.
5.Age 50 years old and over.
6.No other life-threatening illness.
7.Surgery is difficult,surgery has denied herself.
8.Written informed consent

Key exclusion criteria

1.Severe complication
2.Previous treatment
3.Active double primary
4.Tumor invasion to skin or chest wall
5.Distance between tumor border to skin less than 1cm on MRI.
6.Previous irradiation at tumor site
7. Non invasive ductal carcinoma (pure DCIS)
8. Medically, psychologically or other reason who are not suitable for candidate.
9. History of connective tissue diseases

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Hiroyasu
Middle name
Last name Tamamura

Organization

Fukui Prefectural Hospital

Division name

Proton Therapy Center

Zip code

910-8526

Address

2-8-1 Yotsu,Fukui city,Fukui Prefecture,910-8526 Japan

TEL

0776-54-5151

Email

h-tamamura-8e@pref.fukui.lg.jp


Public contact

Name of contact person

1st name Yoshitaka
Middle name
Last name Sato

Organization

Fukui Prefectural Hospital

Division name

Proton Therapy Center

Zip code

910-8526

Address

2-8-1 Yotsu,Fukui city,Fukui Prefecture,910-8526 Japan

TEL

0776-54-5151

Homepage URL


Email

y-satou-xn@pref.fukui.lg.jp


Sponsor or person

Institute

Fukui Prefectural Hospital

Institute

Department

Personal name



Funding Source

Organization

FukuiPrefecture

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukui Prefectural Hospital

Address

2-8-1 Yotsu,Fukui city,Fukui Prefecture,910-8526 Japan

Tel

0776-54-5151

Email

kenbyou@pref.fukui.lg.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

福井県立病院(福井県)


Other administrative information

Date of disclosure of the study information

2015 Year 01 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2014 Year 10 Month 21 Day

Date of IRB

2014 Year 10 Month 21 Day

Anticipated trial start date

2014 Year 10 Month 21 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 01 Month 13 Day

Last modified on

2023 Year 07 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018796


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name